NIH-funded research R01 grant

Malaria Reservoir Study II: lowering parasite variety to help elimination in high-transmission areas

Official title: Malaria Reservoir Study (MRS) II: reducing parasite diversity to break intervention resilience in Plasmodium falciparum populations at high endemicity

Funded at New York University · NIH-11494913 · Data updated 2026-11-12

A study in Ghana aims to see if reducing the variety of malaria parasite strains can help limit transmission and move toward elimination, especially in places with high malaria pressure.

More Resilience research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University
NIH-funded
Lab location1 site (New York, United States)
Project startJune 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$126,204
NIH project number3R01TW013268-01S1
Project IDNIH-11494913 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are residents of study regions in northern Ghana who are part of ongoing malaria surveillance programs and have consented to participate.

Less likely to help

Individuals not enrolled in surveillance or who withdraw from the study may not directly benefit.

What this research studies

This project focuses on Plasmodium falciparum in Ghana to understand how parasite diversity affects ongoing transmission. Researchers will collect detailed longitudinal data and use new molecular tools to track parasite strains over time. The goal is to see if simplifying the parasite population could make existing interventions more effective for communities in sub-Saharan Africa. The findings could inform malaria programs and help communities move closer to elimination as transmission shifts.

Why it matters

Potential benefit: If successful, the work could improve malaria control strategies and support elimination efforts in high-burden regions.

How similar studies have gone: Previous work suggests parasite diversity influences transmission resilience, but this approach tests a specific diversity-reduction strategy in a real-world setting.

Where this research is happening

  • New York University
    New York, United States
    Active

Researchers

  • Principal investigator: Pascual, Mercedes — New York University
  • Study coordinator: Pascual, Mercedes

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.